Clinical Trial Update: A Trial of SHR0302Base in Patients With Vitiligo [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SHR-0302 in patients with vitiligo. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• SHR-0302

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Vitiligo | Phase 2 | Status: ACTIVE_NOT_RECRUITING